ECO Animal Health Group plc (LON:EAH - Get Free Report) shares passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 64.13 ($0.85) and traded as high as GBX 80 ($1.06). ECO Animal Health Group shares last traded at GBX 75.22 ($1.00), with a volume of 54,143 shares changing hands.
Wall Street Analyst Weigh In
Separately, Shore Capital reiterated a "buy" rating and set a GBX 150 ($1.99) price target on shares of ECO Animal Health Group in a report on Monday, July 14th.
Read Our Latest Stock Report on EAH
ECO Animal Health Group Trading Up 0.7%
The business has a 50-day moving average price of GBX 65.30 and a two-hundred day moving average price of GBX 61.48. The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.81. The stock has a market capitalization of £51.50 million, a P/E ratio of 49.13 and a beta of -0.05.
ECO Animal Health Group (LON:EAH - Get Free Report) last issued its quarterly earnings data on Monday, July 14th. The company reported GBX 2.49 ($0.03) earnings per share for the quarter. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.
Insider Activity at ECO Animal Health Group
In related news, insider David Hallas bought 29,897 shares of the business's stock in a transaction that occurred on Tuesday, July 15th. The stock was bought at an average cost of GBX 67 ($0.89) per share, for a total transaction of £20,030.99 ($26,587.46). 21.65% of the stock is owned by insiders.
About ECO Animal Health Group
(
Get Free Report)
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Featured Stories
Before you consider ECO Animal Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ECO Animal Health Group wasn't on the list.
While ECO Animal Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access